Proteomics for the diagnosis of thyroid lesions: preliminary report

Matrix‐assisted laser desorption/ionization (MALDI) imaging mass spectrometry (IMS) is a unique proteomic technology that explores the spatial distribution of biomolecules directly in situ, thus integrating molecular and morphological information. The possibility of correlating distribution maps of multiple analyses with cytological features makes it an ideal research tool for discovering new diagnostic markers. A previous study showed that MALDI‐IMS could help discrimination between different types of thyroid lesions, especially papillary thyroid carcinoma (PTC); the present feasibility study on ex vivo fine needle aspiration (FNA) smears describes its potential in detecting new proteomic targets of other thyroid lesions (follicular lesions, medullary carcinoma).

[1]  Kristina Schwamborn,et al.  Imaging mass spectrometry in biomarker discovery and validation. , 2012, Journal of proteomics.

[2]  Darya Chudova,et al.  Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. , 2012, The New England journal of medicine.

[3]  R. Seethala,et al.  Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. , 2011, The Journal of clinical endocrinology and metabolism.

[4]  S. Crippa,et al.  ‘Indeterminate for malignancy’ (Tir3/Thy3 in the Italian and British systems for classification) thyroid fine needle aspiration (FNA) cytology reporting: morphological criteria and clinical impact , 2014, Cytopathology : official journal of the British Society for Clinical Cytology.

[5]  R. Seethala,et al.  Contribution of molecular testing to thyroid fine‐needle aspiration cytology of “follicular lesion of undetermined significance/atypia of undetermined significance” , 2010, Cancer cytopathology.

[6]  T. Rago,et al.  Presence in the Pre-Surgical Fine-Needle Aspiration of Potential Thyroid Biomarkers Previously Identified in the Post-Surgical One , 2013, PloS one.

[7]  R. Ersoy,et al.  Hürthle cell presence alters the distribution and outcome of categories in the Bethesda system for reporting thyroid cytopathology , 2014, Cytopathology : official journal of the British Society for Clinical Cytology.

[8]  Fulvio Magni,et al.  An Alternative Approach in Endocrine Pathology Research: MALDI-IMS in Papillary Thyroid Carcinoma , 2013, Endocrine Pathology.

[9]  A. Pinchera,et al.  Fine-needle aspiration of thyroid nodules: proteomic analysis to identify cancer biomarkers. , 2008, Journal of proteome research.

[10]  R. Paschke,et al.  Toward the application of proteomics to human thyroid tissue. , 2006, Thyroid : official journal of the American Thyroid Association.

[11]  M. Henry,et al.  Correlation of thyroid nodule fine‐needle aspiration cytology with corresponding histology at Mayo Clinic, 2001–2007: An institutional experience of 1,945 cases , 2012, Diagnostic cytopathology.

[12]  Stephanie L. Lee,et al.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.